ITGA2 Mediates the Resistance of Hepatocellular Carcinoma to Lenvatinib by Activating the AKT/FOXO3A Signaling Pathway.

Cancers (Basel) · 2025 · PMC12427277 · PMID 40940943

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Compared with the Huh7-LR-NC control group, the Huh7-LR-Sh group showed a trend toward a significantly decreased positive rate of Ki67 and a significantly increased positive rate of Caspase-3 ( Figure 4 H).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.